Miranda Broadney, M.D., M.P.H.

Responsibilities & Activities

For investigator-initiated projects, I provide administrative oversight for the Type 1 Diabetes Therapeutics Program which focuses on applications studying the clinical management of type 1 diabetes in youth and adults. This program specifically includes observational and clinical intervention applications studying glycemia, acute events related to T1D, patient reported outcomes including diabetes distress, and/or dissemination and implementation of FDA approved or emerging diabetes evidence-based medicine. This includes insulin regimens, as well as the use of other approved glucose-lowering medications and technologies that might be used as an adjunct to insulin. This additionally includes interventions within the healthcare setting and healthcare delivery space and projects which seek to understand or intervene upon health disparities in T1D. This program does not include the development of novel therapies (such as immunomodulatory therapy) or the development of new technology.

In addition to the Type 1 Diabetes Therapeutics Program, I provide administrative and scientific support for the Glycemic Observation and Metabolic Outcomes in Mothers and Offspring (GO MOMs) and the Understanding the Pathophysiology in Youth Onset T2D consortia.

Committees & Working Groups

• Clinical Advancement based on Research Evidence (CARE), Member
• Growth and Advancement of Researchers in Diabetes & Endocrinology (GARDEN), Co-Chair
• NIDDK Obesity Research Working Group, Member